Bioregenx (BRGX) Return on Equity (2022 - 2026)

Bioregenx has reported Return on Equity for 5 years, with the latest figure at 0.0% in Q1 2026.

• For the quarter ending Q1 2026, Return on Equity fell 6.0% year-over-year to 0.0%; the trailing twelve-month figure through Mar 2026 stood at 0.0% (down 6.0% YoY), and the FY2025 full-year result was 0.0%, down 8.0% from the prior year.
• Return on Equity for Q1 2026 stood at 0.0%, down from 0.0% in the prior quarter.
• The five-year high for Return on Equity was 0.06% in Q1 2025, with the low at 0.04% in Q4 2024.
• Average Return on Equity over 5 years is 0.01%, with a median of 0.0% recorded in 2023.
• Year-over-year, Return on Equity advanced 6 bps in 2025 and retreated 6 bps in 2026.
• Tracing BRGX's Return on Equity over 5 years: stood at 0.0% in 2022, then jumped by 584 bps to 0.0% in 2023, then plunged by 1129 bps to 0.04% in 2024, then surged by 109 bps to 0.0% in 2025, then slipped by 18 bps to 0.0% in 2026.
• The last three Return on Equity figures came in at 0.0% (Q1 2026), 0.0% (Q4 2025), and 0.05% (Q3 2025), per Business Quant data.

Peer Comparison